📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Imara

1.1 - Company Overview

Imara Logo

Imara

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of novel therapeutics for people living with sickle cell disease and hemoglobinopathies.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Imara

DNage Logo

DNage

HQ: The Netherlands Website
  • Description: Provider of life sciences research and development focused on discovering and developing products for aging diseases caused by DNA damage.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DNage company profile →
Protara Therapeutics Logo

Protara Therapeutics

HQ: United States Website
  • Description: Provider of investigational therapies for cancer and rare diseases, including TARA-002, a cell therapy for non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an intravenous phospholipid substrate replacement for patients on parenteral nutrition to address choline deficiency and associated liver damage.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Protara Therapeutics company profile →
Design Therapeutics Logo

Design Therapeutics

HQ: United States Website
  • Description: Provider of GeneTAC small-molecule therapies that modulate gene expression to treat genetic diseases caused by nucleotide repeat expansions. Programs include Friedreich ataxia (DT-216, DT-216P2 to restore FXN), Fuchs endothelial corneal dystrophy (DT-168 eye drop), Huntington's disease (reduce mutant HTT), myotonic dystrophy DM1, and research for additional genetic diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Design Therapeutics company profile →
Oxyrane Logo

Oxyrane

HQ: United Kingdom Website
  • Description: Provider of novel and biosuperior enzyme replacement therapies for lysosomal storage diseases. Pipeline includes OxyGCase for neuronopathic Gaucher disease and OXY2810 for Pompe disease. Offers the OxyCAT glycoengineered yeast-based platform to produce ERTs with enhanced cellular uptake and pharmacodynamics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oxyrane company profile →
Travere Therapeutics Logo

Travere Therapeutics

HQ: United States Website
  • Description: Provider of drug discovery and development for catastrophic, debilitating and often life-threatening diseases, including a non-immunosuppressive medication developed for the treatment of IgA nephropathy, a rare kidney disorder.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Travere Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Imara

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Imara

2.2 - Growth funds investing in similar companies to Imara

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Imara

4.2 - Public trading comparable groups for Imara

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Imara

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Imara

What does Imara do?

Imara is a provider of novel therapeutics for people living with sickle cell disease and hemoglobinopathies.

Who are Imara's competitors?

Imara's competitors and similar companies include DNage, Protara Therapeutics, Design Therapeutics, Oxyrane, and Travere Therapeutics.

Where is Imara headquartered?

Imara is headquartered in United States.

How many employees does Imara have?

Imara has 1,000 employees 🔒.

When was Imara founded?

Imara was founded in 2010 🔒.

What sector and industry vertical is Imara in?

Imara is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Imara

Who are the top strategic acquirers in Imara's sector and industry

Top strategic M&A buyers and acquirers in Imara's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Imara?

Top strategic M&A buyers groups and sectors for Imara include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Imara's sector and industry vertical

Which are the top PE firms investing in Imara's sector and industry vertical?

Top PE firms investing in Imara's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Imara's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Imara's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Imara's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Imara include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Imara's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Imara?

The key public trading comparables and valuation benchmarks for Imara include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Imara for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Imara with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Imara's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Imara with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Imara's' sector and industry vertical?

Access recent funding rounds and capital raises in Imara's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Imara